Ronald L. Klein
Department of Pharmacology
LSUHSC
Shreveport
LA 71130
USA
Name/email consistency: high
- PET imaging in rats to discern temporal onset differences between 6-hydroxydopamine and tau gene vector neurodegeneration models. Klein, R.L., Dayton, R.D., Terry, T.L., Vascoe, C., Sunderland, J.J., Tainter, K.H. Brain Res. (2009)
- Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states. Klein, R.L., Dayton, R.D., Tatom, J.B., Diaczynsky, C.G., Salvatore, M.F. Eur. J. Neurosci. (2008)
- Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Klein, R.L., Dayton, R.D., Leidenheimer, N.J., Jansen, K., Golde, T.E., Zweig, R.M. Mol. Ther. (2006)
- Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model. Klein, R.L., Dayton, R.D., Henderson, K.M., Petrucelli, L. Neurosci. Lett. (2006)
- Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat. Klein, R.L., Dayton, R.D., Lin, W.L., Dickson, D.W. Neurobiol. Dis. (2005)
- Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. Klein, R.L., Lin, W.L., Dickson, D.W., Lewis, J., Hutton, M., Duff, K., Meyer, E.M., King, M.A. Am. J. Pathol. (2004)